Susanna Waters (S Waters)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Parkinson Disease

Mild Cognitive Impairment

Positron Emission Tomography

Top Venues

The Journal of pharmacology and experimental therapeutics

ACS chemical neuroscience

Integrative Research Laboratories Sweden AB

Göteborg University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Integrative Research Laboratories Sweden AB

Sweden

Director of Biology & Biostatistics

Sahlgrenska University Hospital

Sweden

Resident Psychiatrist

Sahlgrenska University Hospital

Sweden

Intern Physician

Education History

Göteborg University

Sweden

PHD

Publications

Susanna Waters, Clas Sonesson, Peder Svensson, Joakim Tedroff, Manolo Carta, Elisabeth Ljung, Jenny Gunnergren, Malin Edling, Boel Svanberg, Anne Fagerberg, Johan Kullingsjö, Stephan Hjorth, Nicholas Waters
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. The Journal of pharmacology and experimental therapeutics 374 (1) (2020)
S Hjorth, Susanna Waters, N Waters, J Tedroff, P Svensson, A Fagerberg, M Edling, B Svanberg, E Ljung, J Gunnergren, S L McLean, B Grayson, N F Idris, J C Neill, C Sonesson
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. The Journal of pharmacology and experimental therapeutics 374 (3) (2020)
Susanna Waters, Peder Svensson, Johan Kullingsjö, Henrik Pontén, Theresa Andreasson, Ylva Sunesson, Elisabeth Ljung, Clas Sonesson, Nicholas Waters
In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. ACS chemical neuroscience 8 (4) (2017)